Animation - Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers
Slide Show - Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers
1.
What is immunotherapy and how does it work for lung cancer?
2.
What types of immunotherapy are used to treat lung cancer?
3.
What side effects can be associated with immunotherapy for lung cancer?
4.
What is comprehensive biomarker testing for lung cancer? What do I need to know?
Expert Video - What types of immunotherapy are used to treat lung cancer?
Medical oncologist Dr. Naomi Fujioka of the University of Minnesota discusses immunotherapy treatment options for non-small cell lung cancer (NSCLC). Immunotherapies are used at different stages of NSCLC. They may be part of your first treatment, used later, or used for advanced cancer that has spread. She talks about a class of drugs called immune checkpoint inhibitors that target either PD-L1 or PD-1. You may have an immunotherapy drug alone, in combination with chemotherapy, or combined with different immunotherapies such as CTLA-4 inhibitors.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
Section: Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers
Expert Videos
Animation - Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers
Slide Show - Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers
1.
What is immunotherapy and how does it work for lung cancer?
2.
What types of immunotherapy are used to treat lung cancer?
3.
What side effects can be associated with immunotherapy for lung cancer?
4.
What is comprehensive biomarker testing for lung cancer? What do I need to know?
